Synlab Sells Swiss Business to Sonic Healthcare for $167.5 Million
By Andrea Figueras
Synlab said Tuesday that it has sold its Swiss operations to Australian peer Sonic Healthcare, which said it is paying 150 million Swiss francs ($167.5 million) for the business.
Munich-based Synlab, a provider of laboratory-diagnostic services, said the deal will be positive for its adjusted earnings margin and allow it to reduce its adjusted net debt. The sale received the required approvals of antitrust authorities, Synlab said.
Sonic separately said it expects the deal will be accretive to earnings per share from next year.
For the second half of 2023, Synlab had expected revenue around 50 million euros ($54.5 million) from its operations in Switzerland. Despite the transaction, which is expected to be closed by July 3, Synlab's revenue guidance for the current year remains the same at around EUR2.7 billion.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
June 27, 2023 04:36 ET (08:36 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom